Response to comments on: Bilateral multifocal choroiditis with disc edema in a 15-year-old girl following COVID-19 vaccination
Indian Journal of Ophthalmology · 2023
DOI: 10.4103/ijo.ijo_2246_22 ↗Kurz gefasst
Leserbrief in der Zeitschrift Indian Journal of Ophthalmology, 2023. Verfasst von Peeyusha Durga Kakarla und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Retina, Sri Venkateswara Aravind Eye Hospital, Tirupathi- 517505, AP, India. Hauptthemen laut MEDLINE: COVID-19, Choroiditis. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Dear Editor, We thank the authors of the letter to the editor for their interest and comments regarding our case report titled “Bilateral multifocal choroiditis with disc edema following COVID-19 vaccination,” published in the September issue of the Indian Journal of Ophthalmology.[1] The concerns raised by the authors have been clarified below with the appropriate references: Vaccine-associated uveitis is a well-reported entity,[2] although uncommon, and causality is difficult to prove. In the most comprehensive review of vaccine-associated uveitis, Benage and Fraunfelder identified 289 such cases, where the median time from vaccination to uveitis was 16 days. Ocular manifestations of the COVID-19 vaccine are not uncommon but relatively mild and transient. Several ophthalmic manifestations of the COVID-19 vaccines have been reported by ophthalmologists.[3] In their extensive review of published literature by Sen et al., definite predilection was not observed, and triggers of inflammation were associated with molecular mimicry, delayed hypersensitivity, and immune complex deposition. As worried by a commenter—we never mentioned in our case report—”Despite its benefits, the COVID-19 vaccination could be dangerous”—we in fact concluded that transient side effects observed by no means are considered a deterrent for vaccination drives in children. The benefit and protection offered by vaccines far outweigh the potential risks. Covaxin showed promising efficacy and safety with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Retina, Sri Venkateswara Aravind Eye Hospital, Tirupathi- 517505, AP, India.
Zitieren
APA
Kakarla, P. D., Venugopal Reddy, Y. C., & Manechala, U. B. (2023). Response to comments on: Bilateral multifocal choroiditis with disc edema in a 15-year-old girl following COVID-19 vaccination. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_2246_22
Vancouver
Kakarla PD, Venugopal Reddy YC, Manechala UB. Response to comments on: Bilateral multifocal choroiditis with disc edema in a 15-year-old girl following COVID-19 vaccination. Indian Journal of Ophthalmology. 2023. doi:10.4103/ijo.ijo_2246_22
BibTeX
@article{Kakarla2023,
author = {Kakarla, Peeyusha Durga and Venugopal Reddy, Y C and Manechala, Upendra Babu},
title = {Response to comments on: Bilateral multifocal choroiditis with disc edema in a 15-year-old girl following COVID-19 vaccination},
journal = {Indian Journal of Ophthalmology},
year = {2023},
doi = {10.4103/ijo.ijo_2246_22}
}
EUVIMED